This bill proposes to establish the Childhood Cancer and Rare Childhood Disease Research Commission, which will be responsible for awarding grants to nonprofit health care providers and research institutions engaged in clinical trials related to pediatric cancer and rare childhood diseases. The current statute regarding the Childhood Cancer and Rare Childhood Disease Research Fund will be amended to include additional funding sources such as legislative appropriations, gifts, donations, and federal grants. The bill also specifies that the Director of the Department of Health Services (DHS) will administer the fund and allocate grants based on the Commission's recommendations.

Key updates include the establishment of the Commission with specific membership requirements, including survivors of childhood cancer and rare diseases, health professionals, and representatives from advocacy organizations. The Commission members will serve five-year terms, will not receive compensation, and will be required to recuse themselves from discussions where conflicts of interest arise. Additionally, the Commission will be mandated to submit an annual report detailing grant distributions and research outcomes starting August 1, 2027. The bill also clarifies that grant funds must be used for their intended purposes, even if combined with other funds.

Statutes affected:
Introduced Version: 36-121, 36-121.01, 28-2442, 35-190
House Engrossed Version: 36-121, 36-121.01, 28-2442, 35-190